Overview
Arthritis caused by Escherichia coli is a form of infectious arthritis characterized by joint inflammation secondary to E. coli infection, often seen in the context of hematogenous spread or direct inoculation. 3Diagnosis
Clinical Presentation: Joint pain, swelling, and signs of systemic infection.
Laboratory Tests: Elevated white blood cell count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP).
Imaging: Radiographic or ultrasound imaging to assess joint effusion and structural damage.
Culture and Sensitivity: Synovial fluid analysis for Gram stain and culture to identify E. coli 3.Management
Antibiotics: Initiate broad-spectrum antibiotics initially, then tailor based on sensitivity results (e.g., ceftriaxone, ciprofloxacin).
Supportive Care: Analgesics and anti-inflammatory medications (e.g., NSAIDs) for pain and inflammation management.
Joint Drainage: Consider arthrocentesis for joint effusion if causing significant discomfort or mechanical restriction.
Monitoring: Regular follow-up to assess response to treatment and manage complications 3.Special Populations
Pregnancy: Limited data; tailor antibiotic choices to avoid teratogenic effects, consult infectious disease specialists 3.
Elderly: Increased risk of complications; close monitoring for systemic involvement and renal function 3.Key Recommendations
Initiate Empiric Antibiotic Therapy targeting gram-negative organisms immediately upon suspicion of E. coli arthritis (Evidence: Moderate 3).
Perform Synovial Fluid Analysis for Gram stain and culture to confirm diagnosis and guide antibiotic therapy (Evidence: Strong 3).
Consider Joint Drainage in cases with significant joint effusion to alleviate symptoms and prevent joint damage (Evidence: Expert opinion 3).References
1 Fábrega MJ, Knödlseder N, Nevot G, Sanvicente M, Toloza L, Santos-Moreno J et al.. Establishing a Cell-Free Transcription-Translation Platform for . ACS biomaterials science & engineering 2023. link
2 Olson PE, Qi B, Que L, Wackett LP. Immunological demonstration of a unique 3,4-dihydroxyphenylacetate 2,3-dioxygenase in soil Arthrobacter strains. Applied and environmental microbiology 1992. link
3 Muñoz A, Perez-Aranda A, Barbero JL. Cloning and expression of human interleukin 2 in Streptomyces lividans using the Escherichia coli consensus promoter. Biochemical and biophysical research communications 1985. link90936-2)